Fenoglio-Preiser C - Search Results

1

The relation of p53 gene mutations to gastric cancer subsite and phenotype.

Tolbert D, Fenoglio-Preiser C, Noffsinger A, De Voe G, MacDonald J, Benedetti J, Stemmermann GN. Tolbert D, et al. Cancer Causes Control. 1999 Jun;10(3):227-31. doi: 10.1023/a:1008899111209. Cancer Causes Control. 1999. PMID: 10454068

2

Esophageal squamous cell carcinomas arising in patients from a high-risk area of North China lack an association with Epstein-Barr virus.

Wang J, Noffsinger A, Stemmermann G, Fenoglio-Preiser C. Wang J, et al. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1111-4. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10613345

3

Alterations in exon 4 of the p53 gene in gastric carcinoma.

Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A, Fenoglio-Preiser C. Shepherd T, et al. Gastroenterology. 2000 Jun;118(6):1039-44. doi: 10.1016/s0016-5085(00)70356-8. Gastroenterology. 2000. PMID: 10833478

4

The relationship of human papillomavirus to proliferation and ploidy in carcinoma of the anus.

Noffsinger AE, Hui YZ, Suzuk L, Yochman LK, Miller MA, Hurtubise P, Gal AA, Fenoglio-Preiser CM. Noffsinger AE, et al. Cancer. 1995 Feb 15;75(4):958-67. doi: 10.1002/1097-0142(19950215)75:4<958::aid-cncr2820750410>3.0.co;2-1. Cancer. 1995. PMID: 7842416

5

The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors.

Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM. Stemmermann G, et al. Hum Pathol. 1994 Oct;25(10):968-81. doi: 10.1016/0046-8177(94)90056-6. Hum Pathol. 1994. PMID: 7927320 Review.

6

Pathologic and phenotypic features of gastric cancer.

Fenoglio-Preiser CM, Noffsinger AE, Belli J, Stemmermann GN. Fenoglio-Preiser CM, et al. Semin Oncol. 1996 Jun;23(3):292-306. Semin Oncol. 1996. PMID: 8658213

7

p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.

Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Stemmermann GN, Macdonald JS, Fenoglio-Preiser CM. Tolbert DM, et al. Mod Pathol. 1999 Jan;12(1):54-60. Mod Pathol. 1999. PMID: 9950163

8

TP53 and gastric carcinoma: a review.

Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. Fenoglio-Preiser CM, et al. Hum Mutat. 2003 Mar;21(3):258-70. doi: 10.1002/humu.10180. Hum Mutat. 2003. PMID: 12619111 Review.

9

beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.

Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM. Clements WM, et al. Cancer Res. 2002 Jun 15;62(12):3503-6. Cancer Res. 2002. PMID: 12067995

10

Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precusors to a preventable cancer.

Stemmermann GN, Fenoglio-Preiser C. Stemmermann GN, et al. Pathology. 2002 Dec;34(6):494-503. doi: 10.1016/s0031-3025(17)30697-9. Pathology. 2002. PMID: 12555987 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page